Wheeler Bio Partners with Charles River for Portable CMC® Solution

Wheeler Bio, Inc., a contract development and manufacturing organization (CDMO), has partnered with Charles River Laboratories International, Inc. to offer the Portable CMC® platform to clients. This collaboration aims to streamline the transition from pre-clinical stages to human clinical trials by combining Charles River’s expertise in antibody discovery services with Wheeler Bio’s innovative technology.

Portable CMC® is a validation-ready production process developed by Wheeler Bio to reduce technical and regulatory risks. The platform operates in state-of-the-art labs in Oklahoma City and Waltham, MA, providing biotechs with a cost-effective path to clinical supply. With modular work packages and industry-leading technology, Wheeler Bio aims to help innovators reach their clinical milestones faster.

Jesse McCool, CEO of Wheeler Bio, highlighted the benefits of integrating discovery CRO and CDMO workflows. By combining insights and expertise, the partnership with Charles River will speed up the path to first-in-human trials, leading to faster clinical decisions.

Julie Frearson, Corporate Senior Vice President at Charles River, expressed excitement about providing clients access to Wheeler’s Portable CMC® platform. This collaboration will optimize workflows and accelerate the development of new treatments for patients.

Wheeler Bio is a biomanufacturing pioneer with a unique hub-and-spoke operational model based in Oklahoma City. The company’s Portable CMC® platform simplifies the path from drug discovery to clinical manufacturing, reducing risk, and lowering costs for innovators. To learn more about Wheeler Bio, visit http://www.wheelerbio.com or follow them on LinkedIn.

In addition, Charles River Laboratories provides essential products and services to pharmaceutical and biotechnology companies worldwide. Their dedicated employees focus on improving research and drug development efforts to bring new therapies to patients in need. For more information about Charles River, visit http://www.criver.com.

ATUM, a California-based CRDO biotechnology leader, offers a range of services from gene design and synthesis to cell line development. With a focus on innovation and bioengineered solutions, ATUM supports the biotech ecosystem from pre-clinical research through IND and beyond. Visit http://www.atum.bio for more information.

This strategic partnership between Wheeler Bio and Charles River Laboratories promises to revolutionize the drug development process by accelerating therapeutic discovery and improving clinical trial timelines. With a focus on collaboration and innovation, both companies are dedicated to bringing new treatments to patients faster.

Source link



Leave a Reply

Your email address will not be published. Required fields are marked *